DK2221309T3 - Aphthyridinderivatmonohydrat og fremgangsmåde til fremstilling deraf - Google Patents

Aphthyridinderivatmonohydrat og fremgangsmåde til fremstilling deraf

Info

Publication number
DK2221309T3
DK2221309T3 DK08855286.4T DK08855286T DK2221309T3 DK 2221309 T3 DK2221309 T3 DK 2221309T3 DK 08855286 T DK08855286 T DK 08855286T DK 2221309 T3 DK2221309 T3 DK 2221309T3
Authority
DK
Denmark
Prior art keywords
aphthyridine
preparing
procedure
mono hydrate
derivative mono
Prior art date
Application number
DK08855286.4T
Other languages
English (en)
Inventor
Taro Kiyoto
Masahiro Takebayashi
Yasutaka Baba
Muneo Syoji
Toshiya Noguchi
Fumihito Ushiyama
Hiroki Urabe
Hiromasa Horikiri
Original Assignee
Taisho Pharmaceutical Co Ltd
Toyama Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd, Toyama Chemical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DK2221309T3 publication Critical patent/DK2221309T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/34Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D309/36Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • C07D309/40Oxygen atoms attached in positions 3 and 4, e.g. maltol
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK08855286.4T 2007-11-26 2008-11-25 Aphthyridinderivatmonohydrat og fremgangsmåde til fremstilling deraf DK2221309T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007304736 2007-11-26
PCT/JP2008/071333 WO2009069589A1 (ja) 2007-11-26 2008-11-25 新規なナフチリジン誘導体1水和物およびその製造法

Publications (1)

Publication Number Publication Date
DK2221309T3 true DK2221309T3 (da) 2013-10-07

Family

ID=40678484

Family Applications (1)

Application Number Title Priority Date Filing Date
DK08855286.4T DK2221309T3 (da) 2007-11-26 2008-11-25 Aphthyridinderivatmonohydrat og fremgangsmåde til fremstilling deraf

Country Status (21)

Country Link
US (1) US8354426B2 (da)
EP (1) EP2221309B1 (da)
JP (1) JP5491195B2 (da)
KR (1) KR20100088693A (da)
CN (1) CN101874032B (da)
AU (1) AU2008330725B2 (da)
BR (1) BRPI0820394A2 (da)
CA (1) CA2706929A1 (da)
CY (1) CY1114936T1 (da)
DK (1) DK2221309T3 (da)
ES (1) ES2426593T3 (da)
HK (1) HK1145179A1 (da)
HR (1) HRP20130860T1 (da)
IL (1) IL205849A0 (da)
MX (1) MX2010005725A (da)
NZ (1) NZ585529A (da)
PL (1) PL2221309T3 (da)
PT (1) PT2221309E (da)
SI (1) SI2221309T1 (da)
WO (1) WO2009069589A1 (da)
ZA (1) ZA201003507B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5398984B2 (ja) 2005-06-24 2014-01-29 富山化学工業株式会社 新規な含窒素複素環化合物およびその塩
SG164384A1 (en) 2006-05-26 2010-09-29 Toyama Chemical Co Ltd Novel heterocyclic compound or salt thereof and intermediate thereof
SG172088A1 (en) 2008-12-12 2011-07-28 Actelion Pharmaceuticals Ltd 5-amino-2-(1-hydroxy-ethyl)-tetrahydropyran derivatives
CN103958525A (zh) 2011-11-30 2014-07-30 埃科特莱茵药品有限公司 3,7-二取代八氢-2H-吡啶并[4,3-e][1,3]噁嗪-2-酮抗生素
US9863798B2 (en) 2015-02-27 2018-01-09 Schneider Electric Systems Usa, Inc. Systems and methods for multiphase flow metering accounting for dissolved gas

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4370002B2 (ja) 1997-08-08 2009-11-25 富山化学工業株式会社 キノロンカルボン酸誘導体またはその塩
GB0031088D0 (en) 2000-12-20 2001-01-31 Smithkline Beecham Plc Medicaments
GB0101577D0 (en) 2001-01-22 2001-03-07 Smithkline Beecham Plc Compounds
AR040336A1 (es) 2002-06-26 2005-03-30 Glaxo Group Ltd Compuesto de piperidina, uso del mismo para la fabricacion de un medicamento, composicion farmaceutica que lo comprende y procedimiento para preparar dicho compuesto
AR040335A1 (es) 2002-06-26 2005-03-30 Glaxo Group Ltd Compuesto de ciclohexano o ciclohexeno, uso del mismo para preparar un medicamento, composicion farmaceutica que lo comprende, procedimiento y compuestos intermediarios de utilidad para preparar dicho compuesto
AR042486A1 (es) * 2002-12-18 2005-06-22 Glaxo Group Ltd Compuesto de quinolina y naftiridina halosustituido en la posicion 3, procedimiento para preparar el compuesto, composicion farmaceutica que lo comprende y su uso para preparar dicha composicion .
EP1471063A1 (en) 2003-02-28 2004-10-27 Exonhit Therapeutics S.A. Compounds and methods of treating cell proliferative diseases, retinopathies and arthritis
MY150958A (en) * 2005-06-16 2014-03-31 Astrazeneca Ab Compounds for the treatment of multi-drug resistant bacterial infections
ATE465163T1 (de) * 2005-12-22 2010-05-15 Glaxo Group Ltd Heterocyclische verbindungen, ihre herstellung und ihre verwendung als antibakterielle mittel
WO2007115947A1 (en) 2006-04-06 2007-10-18 Glaxo Group Limited Pyrrolo-quinoxalinone derivatives as antibacterials
SG164384A1 (en) 2006-05-26 2010-09-29 Toyama Chemical Co Ltd Novel heterocyclic compound or salt thereof and intermediate thereof
EP1992628A1 (en) * 2007-05-18 2008-11-19 Glaxo Group Limited Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones
PE20081551A1 (es) * 2006-07-20 2009-01-09 Glaxo Group Ltd Derivados de quinolona como antibacterianos

Also Published As

Publication number Publication date
US8354426B2 (en) 2013-01-15
WO2009069589A1 (ja) 2009-06-04
IL205849A0 (en) 2010-11-30
PL2221309T3 (pl) 2013-12-31
HRP20130860T1 (en) 2013-10-11
NZ585529A (en) 2012-05-25
AU2008330725A1 (en) 2009-06-04
MX2010005725A (es) 2011-04-11
SI2221309T1 (sl) 2013-10-30
AU2008330725B2 (en) 2013-05-30
CA2706929A1 (en) 2009-06-04
RU2010126085A (ru) 2012-01-10
ZA201003507B (en) 2011-07-27
EP2221309A4 (en) 2011-11-09
CY1114936T1 (el) 2016-12-14
BRPI0820394A2 (pt) 2015-05-19
KR20100088693A (ko) 2010-08-10
JP5491195B2 (ja) 2014-05-14
JPWO2009069589A1 (ja) 2011-04-14
ES2426593T3 (es) 2013-10-24
CN101874032B (zh) 2013-02-06
EP2221309A1 (en) 2010-08-25
EP2221309B1 (en) 2013-07-24
HK1145179A1 (en) 2011-04-08
US20100249417A1 (en) 2010-09-30
PT2221309E (pt) 2013-10-01
CN101874032A (zh) 2010-10-27

Similar Documents

Publication Publication Date Title
DK2222675T3 (da) 5-anilinoimidazopyridiner og fremgangsmåder til deres anvendelse
DK2229360T3 (da) Indolinonderivater og fremgangsmåde til deres fremstilling
IL249906A0 (en) Quinolone analogs and methods related thereto
DK2358669T3 (da) Alpha-keto-persyrer og fremgangsmåder til fremstilling og anvendelse heraf
DK2120591T3 (da) Ny drikkeyoghurt og fremgangsmåde til fremstilling deraf
DK2064222T3 (da) Benzyliske glycosid-derivater og fremgangsmåder til anvendelse deraf
DK3428148T3 (da) Aryloazol-2-yl-cyanoethylaminoforbindelser, fremgangsmåde til fremstilling og fremgangsmåde til anvendelse deraf
DK2147315T3 (da) Diabetesrelaterede biomarkører og fremgangsmåder til anvendelse deraf
DK2270818T3 (da) Polyelektrolyt og fremgangsmåde til fremstilling af polyelektrolytten
EP2200977A4 (en) F1F0-ATPASE INHIBITOR AND ASSOCIATED METHODS
NO20076533L (no) Fremgangsmåte og system for klokkedriftskompensering
DK3338790T3 (da) Oligopeptid-forbindelser og anvendelser deraf
DK2170827T3 (da) Indolin-2-oner og aza-indolin-2-oner
DK2337837T3 (da) Alpha-amylase-blandinger og fremgangsmåder til anvendelse heraf
DK2134663T3 (da) Beskyttelseslag på højtemperaturudholdende chromoxiddannende substrater, og fremgangsmåde til fremstilling deraf
DK2160336T3 (da) Forbindelsesmekanisme og fremgangsmåde
DK2309938T3 (da) Kryokirurgiske systemer og fremgangsmåder til anvendelse heraf
DK2326411T3 (da) Ekstraktionssystem og relateret fremgangsmåde
EP2105435A4 (en) Hydrazone derivatives
DK1999403T3 (da) Multikoblingssystem og fremgangsmåde relateret dertil
DK2036543T3 (da) Granulat og fremgangsmåde til fremstilling deraf
TWI370107B (en) Novel methods for making and using halosilylgermanes
DK2131682T3 (da) Autoklave og fremgangsmåde
EP2175854A4 (en) IMPROVED METHOD FOR THE SYNTHESIS OF SUBSTITUTED FORMYLAMINES AND SUBSTITUTED AMINES
DK2347757T3 (da) Naturlig allicintablet og fremgangsmåde til fremstilling heraf